(Q70149726)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6306193%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Efficacy of ceftriaxone in treatment of serious childhood infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6306193%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

E. G. Chadwick

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6306193

22 September 2023

E. M. Connor

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6306193

22 September 2023

S. T. Shulman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6306193

22 September 2023

R. Yogev

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6306193

22 September 2023

language of work or name

English

0 references

publication date

1 July 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6306193%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

9 October 2019

https://api.elsevier.com/content/article/PII:S0022347683808026?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(83)80802-6

https://api.elsevier.com/content/article/PII:S0022347683808026?httpAccept=text/plain

22 September 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(83)80802-6

The Journal of Pediatrics

22 September 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6306193%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6306193%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6306193%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

141-145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6306193%20AND%20SRC:MED&resulttype=core&format=json

Single-dose ceftriaxone pharmacokinetics in pediatric patients with central nervous system infections

9 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980802-6

Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980802-6

Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980802-6

Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980802-6

Efficacy of ceftriaxone in serious bacterial infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980802-6

Ceftriaxone: in vitro studies and clinical evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980802-6

Ceftriaxone therapy of group B streptococcal bacteraemia and meningitis in infant rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980802-6

Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980802-6

Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980802-6

Clinical evaluation of moxalactam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980802-6

Ceftriaxone (Ro 13-9904) therapy of serious infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980802-6

Double-blind comparison of cefamandole and penicillin in pneumococcal pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980802-6

In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13-9904, and other cephalosporins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980802-6

In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980802-6

Moxalactam in the treatment of pediatric infections

7 January 2021

7

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(83)80802-6

22 September 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6306193%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference